Patient info

Mylan Travel Sickness 15 mg Tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
No longer supplied
Medicine strength:
15 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substance:

Patient leaflet - Mylan Travel Sickness 15 mg tablets

1. What Mylan Travel Sickness Tablets is and what it is used for

Mylan Travel Sickness Tablets contain the active ingredient cinnarizine, which belongs to a group of medicines called anti-histamines.

Cinnarizine is used to control problems with balance (such as Meniere’s disease) which can cause vertigo (a spinning sensation or dizziness), ringing in the ears, nausea (feeling sick), vomiting (being sick) and loss of hearing,

Mylan Travel Sickness Tablets are taken to control travel sickness.

This medicine is for adults and children aged 5 years and over.

How to help stop motion sickness

The following tips may help you avoid travel sickness:

At sea

  • Stay on deck and keep your eyes on the horizon
  • Keep away from diesel and galley smells
  • Do not eat rich and fatty foods while travelling

On the road

  • Keep looking ahead into the distance
  • Travel in daylight with a window open
  • Make sure children can see out of the windscreen
  • Do not read
  • Do not eat rich and fatty foods while travelling

    The product will be referred to Cinnarizine for the remaining portion of this leaflet.

2. What you need to know before you take Mylan Travel Sickness Tablets

Do not take Cinnarizine

  • if you are allergic to cinnarizine or any of the other ingredients of this medicine (listed in section 6).
  • If your child is under 5 years old

Do not take this medicine if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking cinnarizine tablets.

Warnings and precautions

Talk to your doctor or pharmacist before taking Cinnarizine if:

  • you have Parkinson's disease as this medicine may make your condition worse
  • you suffer from liver or kidney problems
  • you have a blood condition called ‘porphyria’

You may still be able to take Cinnarizine tablets, but you should discuss this with your doctor first.

Whilst taking Cinnarizine

If you have a skin (allergy) test, tell the doctor you are taking these tablets, as the tablets can affect skin test results. You will need to stop taking Cinnarizine 4 days before the test.

Other medicines and Cinnarizine

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, This includes medicines that you buy without a prescription, herbal medicines, dietary supplements or vitamins.

In particular tell your doctor or pharmacist if you are taking medicines for:

  • Anxiety
  • Difficulty sleeping
  • Pain
  • Depression

Cinnarizine with alcohol

Alcohol can make you feel more drowsy than normal. Do not drink alcohol whilst taking Cinnarizine.

Pregnancy and breast-feeding

You should not take this medicine during pregnancy or if you are breast-feeding. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Do not drive or operate machinery if you feel drowsy while taking these tablets.

Cinnarizine contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, such as lactose, contact your doctor before taking this medicine.

3. How to take Mylan Travel Sickness Tablets

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure.

Cinnarizine should be taken after food to reduce the risk of stomach upset. The tablets may be sucked, chewed or swallowed whole with water.

Use in adults, elderly and children over 12 years:

The recommended dose is two tablets to be taken two hours before the journey and, if necessary, one tablet taken every eight hours during the journey.

Use in children 5-12 years old:

The recommended dose is one tablet to be taken two hours before the journey and, if necessary, half a tablet taken every eight hours during the journey.

Cinnarizine should not be given to children under 5 years.

If you take more Cinnarizine than you should

If you accidentally take too many tablets or if a young child takes this medicine by accident, contact your doctor or go to your nearest hospital emergency department immediately taking this leaflet and pack with you. You may be sick, feel sick or have an upset stomach, be shaking, have uncontrollable muscle spasms, weakness or floppy muscles, become drowsy or lose consciousness. Young children may also experience seizures.

If you forget to take Cinnarizine

Take the next dose as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a forgotten dose

If you stop taking Cinnarizine

Do not stop taking your treatment without talking to your doctor, even though you may feel better or if you feel the tablets are not working.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Cinnarizine and seek medical help immediately if you have any of the following:

Not known (cannot be estimated from the available data)

allergic reactions such as rash, itching or swelling of the face, lips, tongue, neck or throat or difficulty breathing

red, lumpy, itchy rash which may also have some silvery scales on areas of skin exposed to sunlight

Other possible side effects:

Common (may affect up to 1 in 10 people)

feeling drowsy

nausea

increased weight

Uncommon (may affect up to 1 in 100 people)

Hypersomnia (excessive sleeping)

vomiting

Increased sweating

Skin lesion

Feeling weak

Rare (affects less than 1 in 1,000 people)

  • Indigestion
  • Upper abdominal pain

Not known (cannot be estimated from the available data)

yellow colouration of skin and eyes

problems with your gut

unusual movements, including trembling and shaking of the hands and fingers, uncontrollable twitching or twisting movements or restless legs skin rash with patches of spots, red or pinkish skin, with a crust muscle stiffness

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Mylan Travel Sickness Tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after “EXP”. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Cinnarizine contains

Each tablet contains 15 mg of the active ingredient, cinnarizine.

The other ingredients are maize starch, lactose anhydrous (see section 2 “Cinnarizine contains lactose”), mannitol, magnesium stearate and talc.

What Cinnarizine looks like and contents of the pack

Cinnarizine tablets are white, flat with a bevel edge and marked "G" on both sides. Cinnarizine is available in plastic containers and blister packs of 4, 6, 8, 10, 15, 20, 84 and 100.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Mylan,

Potters Bar,

Hertfordshire,

EN6 1TL,

United Kingdom

Manufacturer

Gerard Laboratories,

35/36 Baldoyle Industrial Estate, Grange road,

Dublin 13,

Ireland

This leaflet was last revised in 05/2021

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04569/0599

Last revision stated in the text: May 2021 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Mylan Travel Sickness 15 mg tablets

Active substance Cinnarizine
Strength 15 mg
Pharmaceutical form Oral tablet
White, flat bevel edged tablets marked “G” on both sides
How is it taken Oral
Excipients Maize starch,, Lactose, anhydrous,, Mannitol,, Magnesium stearate,, Talc.
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage No special precautions for storage.
Drug group (ATC) Antivertigo preparations
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07C Antivertigo preparations
        1. N07CA Antivertigo preparations
          1. N07CA02 cinnarizine
Marketing authorisation PL 04569/0599 (first authorised 20 June 2008)
Marketing authorisation holder Generics [UK] Ltd. t/a Mylan
Codes BNF 04060000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.